In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
Oxidative stress occurs when there is an imbalance between unstable molecules called free radicals and the antioxidants meant to neutralize them
Giustarini, et al., J
The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
(2008), who assessed an increasing trend of inhibitory activity of kefiran against Bacillus cereus B10502 when administered at a dosage increasing from 300 to 1000 mg/L
Unreconstituted lyophilised powders remain stable at room temperature for brief periods during transport, but long-term storage demands dedicated refrigeration between 2 and 8 degrees Celsius or freezing at minus 20 degrees Celsius